Citanest Forte Dental Injection, Solution
Product Images NDC 66312-580

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Citanest Forte Dental (NDC 66312-580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dentsply Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Citanestforte 01

Chemical structure of prilocaine hydrochloride, showing the molecular arrangement including a benzene ring attached to an amide group, a side chain with methyl and ethyl groups, and a hydrochloride (HCl) component.*

FDA Label Image

Citanestforte 02

Chemical structure of the active ingredient, depicting a molecular diagram with hydroxyl groups attached to a benzene ring and an adjacent carbon with a side chain, corresponding to prilocaine HCl and epinephrine components in Citanest Forte DENTAL injection solution.*

FDA Label Image

Citanestforte 03

Label for Citanest Forte DENTAL 4% injection solution with Epinephrine 1:200,000, a submucosal injectable dosage form containing prilocaine HCl and epinephrine. Manufactured for Dentsply Pharmaceutical Inc., this package includes 50 single-dose cartridges of 1.8 mL each. Storage instructions and ingredient details are also present on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.